Mitoxantrone encapsulated nanocells - EnGeneIC

Drug Profile

Mitoxantrone encapsulated nanocells - EnGeneIC

Alternative Names: EGFREDVMitoxantrone; EEDVSMit; EGFR-ErbituxEDVsMIT; Kid EDV; Mitoxantrone packaged EDV™ nanocells - EnGeneIC; Mitoxantrone packaged EnGeneIC Delivery Vehicle; Mitoxantrone packaged EnGeneIC Dream Vector

Latest Information Update: 15 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator EnGeneIC
  • Class Anthraquinones; Antineoplastics; Small molecules
  • Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I CNS cancer; Solid tumours

Most Recent Events

  • 28 Jan 2016 Engeneic plans the phase I ECREST trial for Solid tumours and CNS cancer (Second-line therapy or greater, Recurrent, In children, In adolescents) in Australia (IV, injection) (NCT02687386)
  • 27 Jan 2016 Preclinical trials in CNS cancer and Solid tumours in Australia (IV) before January 2016
  • 07 Oct 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top